ENTA MEXC RealStocks
Own real ENTA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 22:08:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Enanta Pharmaceuticals, Inc. (ENTA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $11.18, with a market capitalization of $326.79M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.05 to $17.15. This page covers its latest market performance, valuation, price trends and company information.
$326.79M | |
$11.55 | |
$12.00 | |
$11.09 | |
$11.60 | |
226.65K | |
264.17K | |
-- | |
$17.15 | |
$10.05 | |
-- | |
-- |
Enanta Pharmaceuticals, Inc. (ENTA) is trading at $11.18 in after-hours trading as of 2026-11-12 21:16:00, up 0.01% ($0.00) from the regular-session close of $11.18.
After-hours trading shows how investors are pricing ENTA after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Enanta Pharmaceuticals, Inc. (ENTA) moved from $10.37 to $11.18, representing a gain of 7.80% ($0.81).
The stock traded between $10.05 and $12.00 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 291.59 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 15.9%
ENTA is currently trading at $11.18, placing it 15.9% of the way from its 52-week low of $10.05 to its 52-week high of $17.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 120 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Enanta Pharmaceuticals, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Enanta Pharmaceuticals, Inc. (ENTA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ENTA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ENTA shares and USD.
ENTA Shares to USD
1.00 ENTA shares = 11.179 USD
Calculations are estimates based on the latest available price and are for reference only.